Jump to content

NSCLC Survey Opportunity Feb 12, 2018


Recommended Posts



Survey research opportunity for patients with non-small cell lung cancer.

If you have been diagnosed with metastatic non-small cell lung cancer (NSCLC), you may be able to participate in a survey study.

ICON is a global health research company contracted by pharmaceutical companies to conduct research. ICON is looking for U.S. patients to participate in a survey for people who have been diagnosed with metastatic NSCLC with a genetic mutation called ‘EGFR.’ The purpose of this study is to gain insight into the preferences of patients for treatment.

This study consists of a one-time online survey that will take about 30 minutes to complete. Participants will receive $30 if they are eligible and complete the entire survey. The deadline to complete this survey is February 25th.

Please send a note to contact@patientip.com for more information on this opportunity.



Link to comment
Share on other sites

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.